Localization of major neutralizing epitopes on the S1 polypeptide of the murine coronavirus peplomer glycoprotein
- PMID: 1645909
- PMCID: PMC7133859
- DOI: 10.1016/0168-1702(91)90011-j
Localization of major neutralizing epitopes on the S1 polypeptide of the murine coronavirus peplomer glycoprotein
Abstract
A recombinant baculovirus system has been used to express the amino terminal half of the murine coronavirus (JHMV) peplomer glycoprotein in insect cells. The expressed polypeptide is glycosylated and is recognized by a set of monoclonal antibodies (mAbs) specific for JHMV S protein. Three of these mAbs have a very high neutralizing activity for JHMV but not for other MHV strains. These results indicate that JHMV-specific, major neutralizing epitopes reside in the amino terminal S1 subunit of the peplomer glycoprotein.
Similar articles
-
Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein.J Virol. 1994 Sep;68(9):5403-10. doi: 10.1128/JVI.68.9.5403-5410.1994. J Virol. 1994. PMID: 7520090 Free PMC article.
-
Expression of the peplomer glycoprotein of murine coronavirus JHM using a baculovirus vector.Virology. 1989 Dec;173(2):615-23. doi: 10.1016/0042-6822(89)90573-4. Virology. 1989. PMID: 2556844 Free PMC article.
-
Expression of the spike protein of murine coronavirus JHM using a baculovirus vector.Adv Exp Med Biol. 1990;276:211-6. doi: 10.1007/978-1-4684-5823-7_29. Adv Exp Med Biol. 1990. PMID: 1966405
-
Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure.J Virol. 1993 Mar;67(3):1185-94. doi: 10.1128/JVI.67.3.1185-1194.1993. J Virol. 1993. PMID: 7679743 Free PMC article.
-
Localization of neutralizing epitopes and receptor-binding site in murine coronavirus spike protein.Adv Exp Med Biol. 1995;380:359-65. doi: 10.1007/978-1-4615-1899-0_58. Adv Exp Med Biol. 1995. PMID: 8830508
Cited by
-
Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.J Virol. 2004 Jul;78(13):6938-45. doi: 10.1128/JVI.78.13.6938-6945.2004. J Virol. 2004. PMID: 15194770 Free PMC article.
-
A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination.Vet Microbiol. 1993 Jul;36(1-2):1-37. doi: 10.1016/0378-1135(93)90126-r. Vet Microbiol. 1993. PMID: 8236772 Free PMC article. Review.
-
Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus.Adv Pharm Bull. 2016 Mar;6(1):91-98. doi: 10.15171/apb.2016.014. Epub 2016 Mar 17. Adv Pharm Bull. 2016. PMID: 27123423 Free PMC article.
-
Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus.Virology. 1991 Dec;185(2):732-40. doi: 10.1016/0042-6822(91)90544-l. Virology. 1991. PMID: 1660201 Free PMC article.
-
SJL/J resistance to mouse hepatitis virus-JHM-induced neurologic disease can be partially overcome by viral variants of S and host immunosuppression.Microb Pathog. 1992 Jul;13(1):1-15. doi: 10.1016/0882-4010(92)90027-l. Microb Pathog. 1992. PMID: 1331698 Free PMC article.
References
-
- Cavanagh D., Davis P.J., Darbyshire J.H., Peter R.W. Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or hemagglutination-in- hibiting antibody, or induce chicken tracheal protection. J. Gen. Virol. 1986;67:1435–1442. - PubMed
-
- Delmas B., Rasschaert D., Godet M., Gelfi J., Laude H. Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike glycoprotein S. J. Gen. Virol. 1990;71:1313–1323. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources